ChemicalBook > CAS DataBase List > Vepalimomab

Vepalimomab

Product Name
Vepalimomab
CAS No.
195158-85-1
Chemical Name
Vepalimomab
Synonyms
Vepalimomab;Research Grade Vepalimomab;Research Grade Vepalimomab (DHH39203)
CBNumber
CB38080803
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

Vepalimomab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Vepalimomab Suppliers

China 11 Global 11
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ：422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
6762
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58
Changsha Fuzhen Biotechnology Co.，LTD
Tel
0731-13823398 15111215862
Email
313359644@qq.com
Country
China
ProdList
4161
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
10001
Advantage
58
AntibodySystem Laboratories SAS
Tel
33175446423
Email
support@antibodysystem.com
Country
China
ProdList
6739
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58
Guangzhou Chuangze Biotechnology Co., Ltd.
Tel
18312220236
Country
CHINA
ProdList
178
Advantage
58

195158-85-1, VepalimomabRelated Search:

Gontivimab Lesofavumab Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer Brolucizumab Trevogrumab Oxelumab Demcizumab Ralpancizumab Tenatumomab Begelomab

  • Vepalimomab
  • Research Grade Vepalimomab (DHH39203)
  • Research Grade Vepalimomab
  • 195158-85-1